MediciNova, Inc.
MNOV
$1.52
-$0.07-4.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -100.00% | -- | -- | -- |
| SG&A Expenses | 4.54% | -10.29% | -13.42% | -9.93% | -4.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.29% | 2.92% | -19.21% | -21.92% | -25.49% |
| Operating Income | -28.03% | -12.60% | 26.68% | 28.97% | 32.32% |
| Income Before Tax | -28.89% | -8.20% | 34.39% | 38.18% | 39.09% |
| Income Tax Expenses | 83.33% | 7.14% | 7.14% | 7.14% | 7.14% |
| Earnings from Continuing Operations | -28.91% | -8.20% | 34.38% | 38.17% | 39.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.91% | -8.20% | 34.38% | 38.17% | 39.08% |
| EBIT | -28.03% | -12.60% | 26.68% | 28.97% | 32.32% |
| EBITDA | -28.08% | -12.60% | 26.74% | 29.04% | 32.38% |
| EPS Basic | -28.95% | -8.25% | 34.40% | 38.15% | 39.05% |
| Normalized Basic EPS | -28.85% | -8.17% | 34.38% | 38.16% | 39.06% |
| EPS Diluted | -30.75% | -8.20% | 33.84% | 37.59% | 39.74% |
| Normalized Diluted EPS | -28.85% | -8.17% | 34.38% | 38.16% | 39.06% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |